Pile of newspapers on white background

Blog

image-

4th Annual mRNA Process Development & CMC Summit

Posted on

Ready to accelerate innovation in mRNA therapies? LineaRx is proud to announce we will be exhibiting at the 4th mRNA Process Development & CMC Summit, happening September 23–25, 2025, at the Hilton Boston Logan Airport, Boston, MA. The summit will spotlight groundbreaking topics, from self-amplifying RNA (saRNA) and circRNA to digital twins, inline analytics, and […]

Read More email

image-

CAR-TCR Summit 2025

Posted on

LineaRx is excited to be attending the 10th CAR‑TCR Summit, the world’s premier cell therapy forum, taking place September 23–26, 2025, in Boston, MA at the Marriott Copley. At this milestone 10th Anniversary event—featuring end-to-end coverage from Discovery & Translation through late-stage manufacturing and analytical development—we’ll be exchanging ideas on innovations in CAR‑T, TCR, and more. Why […]

Read More email

image-

Linea™IVT — better RNA, faster

Posted on

For More Information,call (631) 240-8877 or Email Us Skip to toolbar

Read More email

image-

DNA Made Simple

Posted on

For More Information,call (631) 240-8877 or Email Us Skip to toolbar

Read More email

image-

APDN Announces New Follow-On LineaDNA™ Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Posted on

STONY BROOK, N.Y., – July 24, 2025 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in synthetic DNA manufacturing powered by scalable PCR platforms, today announced it received a seventh follow-on order valued at more than $600,000 for a multi-gram quantity of LineaDNA™. The follow-on order was placed by […]

Read More email

image-

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Posted on

Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth STONY BROOK, N.Y. – June 30, 2025 – Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in PCR-based DNA technologies, announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part of actions undertaken, the Company implemented […]

Read More email

image-

LineaRx Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Posted on

Pivot to U.S.-based Supply Chain for Critical Input Materials Completed STONY BROOK, N.Y. April 21, 2025 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, Inc., the Company’s majority-owned subsidiary, has completed a long-term initiative to source critical input materials for its […]

Read More email

image-

2nd Annual DNA Process Development & Manufacturing Summit: March 26-27

Posted on

LineaRx, an Applied DNA company, will showcase its Linea™ IVT and Linea™ DNA platforms at the upcoming DNA Process Development & Manufacturing Summit, in Boston, MA. March 26-27, 2025 Team members will be available during the show for one-on-one meetings. Email info@adnas.com to schedule a meeting today!

Read More email

image-

World Vaccine Congress: April 21-24

Posted on

LineaRx, an Applied DNA company, will showcase its Linea™ IVT and Linea™ DNA platforms at the upcoming World Vaccine Congress, to be held April 21 – 24, 2025 at the Walter E. Washington Convention Center in Washington, D.C. We are exhibiting at Booth 479. Team members will be available during the show for one-on-one meetings. Email […]

Read More email